What does a search ad sell when no medicine is for sale? Pharma public affairs advertising often promotes a policy position rather than a specific medicine. A study published November 2, 2026, estimates that PhRMA spent $58.8 million on paid search between February 2019 and December 2025. The finding raises a larger question: When someone searches for answers about healthcare policy, whose explanation do they see first?
Table of Contents
- What the $58.8 Million Estimate Actually Measures
- Why PBMs Became a Central Public Affairs Message
- How Paid Search Shapes the Drug-Pricing Debate
- What Healthcare Marketers and Readers Can Learn
- Conclusion
- Frequently Asked Questions
What the $58.8 Million Estimate Actually Measures
Researchers Daniel Eisenkraft Klein and Aaron S. Kesselheim examined PhRMA’s paid search activity using Semrush, a digital marketing intelligence platform. Their November 2026 analysis tracked keyword activity and landing pages from February 2019 through December 2025.
Across that period, they estimated $58.8 million in spending, 283,517 keyword instances, and 17.1 million paid visits to PhRMA web properties. Importantly, these are third-party estimates, not PhRMA billing records. They cannot establish how viewers understood the messages or whether the advertising changed anyone’s opinion.
Insurance and health plan terms accounted for approximately $32.4 million, or 55.1% of estimated spending. Some terms covered insurance broadly, including non-health policies. Another $27.9 million, representing 47.5% of the total, directed traffic to pages the researchers classified as critical of pharmacy benefit managers, or PBMs.
These figures reveal how extensively paid search can be used to distribute healthcare policy messages. However, the number of clicks and estimated advertising dollars tells only part of the story. Understanding the campaign also requires examining the arguments presented to people who encountered those ads.
Why PBMs Became a Central Public Affairs Message
Pharmacy benefit managers help administer prescription drug benefits for health plans and employers. For example, they negotiate drug rebates, develop lists of covered medicines, and manage pharmacy networks. Their role has become increasingly important in national debates about prescription drug affordability.
PhRMA has long emphasized rebates, middlemen, and insurance practices in its public discussions of medicine prices. Its criticism of PBMs offers an alternative to narratives that focus mainly on the prices drugmakers charge.
There are legitimate policy questions surrounding how PBMs operate. A 2024 Federal Trade Commission staff report raised concerns about PBM concentration, vertical integration, and pharmacy access. Meanwhile, drug manufacturers also influence prescription costs through pricing and contracting decisions.
As Pharma Marketing Network has explored, employers and benefits groups are increasingly important audiences in healthcare communications. These stakeholders often make decisions that affect coverage and prescription drug access.
For a pharmaceutical trade association, reaching people while they research these issues can be especially valuable. Instead of waiting for audiences to encounter a traditional policy advertisement, paid search places an organization’s message near information people are actively seeking.
Still, visibility should not be confused with neutrality. A trade association’s explanation may contain useful information while also reflecting the interests of the organizations it represents.
How Paid Search Shapes the Drug-Pricing Debate
Someone searching for information about prescription drug prices may encounter a sponsored result linking to an advocacy website. That page might offer an explanation of rising healthcare costs, but it may also emphasize one stakeholder’s preferred interpretation of the problem.
Advertisers do not own search queries. Instead, they bid for opportunities to display messages alongside relevant searches. When a sponsored result appears prominently, it may become one of the first explanations a reader encounters.
That gives advertisers a chance to reach people just as they begin searching for answers about healthcare policy. Unlike a conventional display advertisement, search advertising responds to a question or topic already on the user’s mind.
The timing of PhRMA’s spending makes this approach particularly noteworthy. Researchers identified a peak of approximately $4.8 million in May 2023. In addition, the period from March through September 2023 accounted for 36.5% of the estimated spending across the entire study window.
These spending surges coincided with major developments in drug-pricing policy. However, the study found little linear relationship between monthly advertising spending and the Google Trends measure the researchers selected.
Consequently, the findings document significant bursts of paid search activity without establishing exactly what caused them. The research also did not measure whether people who encountered the advertisements changed their opinions.
This distinction matters. Sponsored search results can increase exposure to a particular message, but greater exposure does not automatically produce agreement. Readers may accept an argument, reject it, or seek additional information before forming an opinion.
In a complex debate involving drug manufacturers, insurers, PBMs, employers, and patients, the first explanation someone encounters can influence the information they examine next. Yet determining whether that exposure changes public attitudes requires research beyond advertising traffic estimates.
What Healthcare Marketers and Readers Can Learn
Pharma Marketing Network’s earlier coverage of pay-per-click advertising examined targeting, engagement, and campaign performance. Public affairs campaigns introduce an additional challenge because their goals often extend beyond traditional marketing outcomes.
Rather than promoting a particular prescription medicine, these campaigns may address reimbursement rules, insurance practices, healthcare intermediaries, or pending legislation. Therefore, counting clicks alone provides an incomplete picture of success.
For healthcare marketing teams, measuring the success of a policy campaign takes more than counting clicks. Advertisers also need to understand whether audiences recognize the sponsor, understand the claims, and can distinguish supporting evidence from policy advocacy.
In digital healthcare advertising, these considerations are particularly important because health-related information can influence how people understand treatment access, affordability, and public policy.
Transparency should be part of the conversation. Sponsored messages should clearly identify their commercial or organizational source. Likewise, landing pages should present factual claims accurately and avoid creating misleading impressions through selective information.
Campaign evaluation can also examine engagement quality, audience understanding, and changes in awareness. However, marketers should avoid presenting website visits as evidence of persuasion unless they have research that directly supports that conclusion.
For readers, the lesson is equally practical. A sponsored result may provide useful information, but it is worth checking who funded the message, what evidence supports its claims, and whether other credible sources offer different perspectives.
Ultimately, visibility and credibility are different things. Effective communication can attract attention, while trustworthy communication helps audiences make informed judgments.
Conclusion
PhRMA’s estimated $58.8 million search campaign illustrates how healthcare policy arguments can reach audiences through everyday online searches. Nearly half of the estimated spending directed traffic to pages researchers classified as critical of PBMs, while major spending surges occurred during periods of intense drug-pricing debate.
However, the research does not establish that these advertisements changed public opinion or influenced policy outcomes. The bigger story is how sponsored search results can make one stakeholder’s interpretation among the first explanations people encounter.
For healthcare marketers, the findings highlight the growing connection between search visibility, public affairs messaging, and trust. For everyone following the drug-pricing debate, they offer a reminder that the first answer in a search is not necessarily the complete picture.
Frequently Asked Questions
What is pharma public affairs advertising?
It is advertising designed to explain or promote an organization’s position on healthcare policy, regulation, or industry issues rather than market a specific prescription medicine. Campaigns may use paid search, digital media, and other channels to reach audiences interested in those topics.
Did PhRMA actually spend $58.8 million on search ads?
The study estimates $58.8 million in pay-per-click spending linked to PhRMA web properties between February 2019 and December 2025. Researchers used Semrush data rather than verified advertising invoices, so the figure should be treated as an estimate.
Why did PhRMA focus its messaging on PBMs?
PBMs play a significant role in prescription drug coverage and payment. PhRMA has argued that these intermediaries deserve greater scrutiny when policymakers discuss medicine affordability. The debate also involves manufacturers, insurers, employers, and other healthcare stakeholders.
Can paid search advertising influence public opinion about healthcare policy?
Paid search can increase the visibility of a particular argument when people look for information. However, exposure does not necessarily mean persuasion. The PhRMA spending analysis did not measure changes in public attitudes, voting behavior, or policy outcomes.
How can healthcare marketers evaluate public affairs campaigns?
Marketers can examine campaign reach, engagement quality, message understanding, and sponsor transparency. When possible, audience research can help determine whether communications improved knowledge or awareness. Website traffic alone cannot establish that a campaign changed people’s views.
This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.
